Shares of insurance company Humana (HUM.US) are losing 15% today, after the company indicated to the Securities and Exchange Commission that its ratings for so-called Medicare Advantage plans have dropped significantly. The share of customers enrolled in the 2025 plans fell to 25%, down from 94% this year. These plans, are private equivalents of the government's Medicare program, (designed for people 65 and older). The annual enrollment window for 2025 insurance begins Oct. 15, and customers will have until Dec. 7 to decide on coverage.
The insurer said the results of the assessments are not expected to affect its performance in the current and next year's 2025, but will negatively affect revenues starting in 2026.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app- Based on preliminary 2025 data from the Centers for Medicare & Medicaid Services (CMS), only 1.6 million, or 25%, of its members are currently enrolled in individual plans for next year.
- The main culprit is a drop in ratings for one of Humana's key contracts, in which 45% of its members are enrolled. Ratings have dropped from 4.5 stars to 3.5 stars, and the contract represents more than 90% of group Medicare Advantage plans.
- The company estimates that the drop in ratings is due to a change in the way they are calculated, which may still be wrong, and will await clarification, by CMS. The company is currently trying to resolve the issue and minimize the impact.
- BTIG indicated that Humana's ratings were disappointing, given that plans are already facing problems - higher claims and rising hospital visits.
Humana (HUM.US, D1 interval)
Humana intends to provide more details in the next few months on future strategies to improve performance. It reported that it is taking steps to increase member and provider engagement, improve technology and enhance customer service. However, investors are very cautious. Shares of the Humana are now set at $237, near Covid-19 lows, much below EMA200 (red signal).
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
